ARCHIVES

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Rates Decline Most for Affluent White Women

February 26, 2010

Lombardi Center, Virgin Islands Collaborate On Patient Care

August 7, 1981

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

August 14, 1992

Obey Attacks NCI In Campaign Speech

October 29, 1976

Research teams link response to Iressa to mutations in EGF receptor.

April 30, 2004

Researcher Falsified EMF Data, ORI Says

July 30, 1999